CIP Dining Series: FDA Readiness as a Valuation Multiplier

DA Readiness as a Valuation Multiplier | CIP Impact Dining Series (with Michel Moravia)

📅 Tuesday, Sept 23, 2025 | 🕠 6:00 – 8:30 PM📍 Waltham, MA |(easy parking)🍽️ Private Dinner | 👥 Limited to 12 Guests

💡 Why This Dinner MattersIn MedTech, clinical milestones and market size often dominate the conversation. But the real multiplier for valuation is FDA readiness.

A strong regulatory strategy doesn’t just accelerate approvals — it builds investor confidence, unlocks funding, and increases company value.

This evening will feature Michel E. Moravia, MBA, MSE — CEO of Quality Means Business (QMB, Inc.), a “40 Under 40” life science leader, and MedTech regulatory innovator. Michel will share real-world cases showing how proactive FDA strategy can change the trajectory of startups and portfolios alike.

👥 Attendance is CuratedPriority will be given to:

• Founders of MedTech or Digital Health startups preparing for fundraising or regulatory submissions
• Investors seeking to de-risk and strengthen their portfolio companies(Select seats may be available for advisors and partners directly supporting these journeys.)

🌟 What to Expect

• Curated Conversation: Small group, meaningful access — not a large panel or mixer
• Practical Insight: Strategies that connect FDA readiness with valuation
• Premium Experience: Fine dining setting in Waltham, designed for thoughtful exchange

🎟 RegistrationLimited to 12 seats. Applications are reviewed on a rolling basis. Venue details will be shared upon confirmation.

✨ CIP Impact Dining Series is hosted by Cambridge Innovation Partners, with the support of TopContenders and MZ Services Inc., as part of our mission to connect founders, investors, and innovators.

📸 Photo/Media DisclaimerPhotos or video may be captured during the event. By attending, you grant permission for use in future outreach and documentation.

Also check out other Business events in Waltham, Health & Wellness events in Waltham.